Papers on bisphosphonate
292 papers15 new in 30 days
Monday, June 23
Friday, June 20
Wednesday, June 11
The Journals of Gerontology, Series A
Longitudinal associations between medication use and phenotypic aging: insights from the Baltimore longitudinal study of aging
Cohort study in peoplePopulations
Monday, June 9
JBMR Plus
Association of exercise and race/ethnicity with atypical femur fracture
Cohort study in peopleBones and joints
Wednesday, June 4
Osteoporosis International
Asia-Pacific consensus for the management of osteoporosis in men
ReviewIndustry & policy
Wednesday, May 28
Sunday, May 25
Tuesday, April 8
bioRxiv
Bisphosphonates Trigger Anti-Ageing Effects Across Multiple Cell Types and Protect Against Senescence
Preprint: non-randomized trial in peopleBisphosphonates
Friday, March 28
Monday, March 17
Investigative Ophthalmology & Visual Science
NLRP3 Activation With Bisphosphonate Use and the Risk of Incident Age-Related Macular Degeneration
Cohort study in peopleAge-related macular degeneration
Saturday, January 25
Journal of Clinical Medicine
Analysis of Preventive Effect of Bisphosphonate for Osteoporotic Fracture in Patients with Alzheimer's Disease and Patient Mortality
Cohort study of 43,469 peopleBisphosphonates
Thursday, January 23
Current Research in Translational Medicine
Trends in drug repurposing: Advancing cardiovascular disease management in geriatric populations
ReviewCardiovascular disease
Wednesday, January 8
Monday, December 9
Wednesday, December 4
Sunday, November 24
Osteoporosis and Sarcopenia
Osteoporosis in men-East and West: Can the twain meet? A perspective from Asia
ReviewOsteoporosis
Thursday, October 24
Wednesday, October 23
Archives of Osteoporosis
Risk of first hip fracture under treatment with zoledronic acid versus alendronate: a NOREPOS cohort study of 88,000 Norwegian men and women in outpatient care
Cohort study in peopleAlendronate
Friday, September 27
The Lancet Diabetes & Endocrinology
Osteopenia: a key target for fracture prevention
ReviewBone fracture
Thursday, September 19
Contemporary Clinical Trials
The Bone, Exercise, Alendronate, and Caloric Restriction (BEACON) trial design and methods
Study protocolDietary restriction
Thursday, September 12
Expert Opinion on Drug Safety
The use of denosumab in osteoporosis - an update on efficacy and drug safety
ReviewDenosumab
Thursday, September 5
Archives of Osteoporosis
Clinical characteristics and risk factors of osteoporosis among older Asian men with type-2 diabetes mellitus, hypertension, or hyperlipidaemia
Cohort study of 17,644 peopleOsteoporosis
Wednesday, August 28
Monday, August 12
Geriatric Orthopaedic Surgery & Rehabilitation
A 10-Year Experience of an Integrated Geriatric Hip Fracture Treatment Protocol: Outcomes at a Minimum 2-Year Follow-Up
Cohort study of 1,280 peopleFragility fracture
Saturday, August 3
Internal and Emergency Medicine
Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system's inhibitor denosumab vs. bisphosphonates
Study of 60 peopleDenosumab
Wednesday, April 17
The Journal of Clinical Endocrinology and Metabolism
Effect of Oral Bisphosphonate Drug Holiday on Mortality Following Hip Fracture
Cohort study of 365 peopleHip fracture
Tuesday, April 16
Biochemical and Biophysical Research Communications
Conditioned medium of human mesenchymal stem cells affects stem cell senescence in osteoporosis
Experiments in micePostmenopausal osteoporosis
Tuesday, March 26
Annals of Joint
A narrative review of the pharmaceutical management of osteoporosis
ReviewOsteoporosis
Tuesday, March 19
Journal of Bone and Mineral Research
Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project
Meta-analysis of randomized trialsVertebral fracture